Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Soluble Vascular Endothelial-cadherin in Prediction and Diagnosis of Early Postoperative Hypoxemia After Cardiopulmonary Bypass

NCT05647382 is registered in ClinicalTrials.gov with Zhuan Zhang as lead sponsor.

NCT NCT05647382
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05647382 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Soluble Vascular Endothelial-cadherin in Prediction and Diagnosis of Early Postoperative Hypoxemia After Cardiopulmonary Bypass
Lead sponsor
Zhuan Zhang
Phase
Not applicable
Overall status
Completed
Start date
February 1, 2022
Completion date
November 1, 2022
Enrollment
100 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

ards, cardiopulmonary bypass, hypoxemia, lung injury, acute